Literature DB >> 18194408

German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.

J-Matthias Graf von der Schulenburg1, Wolfgang Greiner, Fred Jost, Norbert Klusen, Maria Kubin, Reiner Leidl, Thomas Mittendorf, Herbert Rebscher, Oliver Schoeffski, Christoph Vauth, Timm Volmer, Steffen Wahler, Juergen Wasem, Christian Weber.   

Abstract

Mesh：

Year:  2008        PMID： 18194408     DOI： 10.1111/j.1524-4733.2007.00301.x

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  53 in total

1.  Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis.

Authors:  Mareike Schad; Jürgen John
Journal:  Eur J Health Econ       Date:  2010-12-19

2.  [Patients suffering from atrial fibrillation in Germany. Characteristics, resource consumption and costs].

Authors:  T Reinhold; S Rosenfeld; F Müller-Riemenschneider; S N Willich; T Meinertz; P Kirchhof; B Brüggenjürgen
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

3.  Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany.

Authors:  Sebastian Braun; Thomas Mittendorf; Thomas Menschik; Wolfgang Greiner; Johann-Matthias von der Schulenburg
Journal:  Breast Care (Basel)       Date:  2009-12-11       Impact factor: 2.860

4.  Methods of economic evaluation for the German statutory healthcare system.

Authors:  Thomas Mittendorf; Wolfgang Greiner; Johann-Matthias von der Schulenburg
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  The cost of post-burn scarring.

Authors:  U Mirastschijski; J T Sander; U Zier; H O Rennekampff; B Weyand; P M Vogt
Journal:  Ann Burns Fire Disasters       Date:  2015-09-30

6.  Conceptual framework for standard economic evaluation of physical activity programs in primary prevention.

Authors:  Silke B Wolfenstetter
Journal:  Prev Sci       Date:  2011-12

7.  Do economic evaluations of targeted therapy provide support for decision makers?

Authors:  Ilia L Ferrusi; Natasha B Leighl; Nathalie A Kulin; Deborah A Marshall
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

8.  Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.

Authors:  Hiltrud Liedgens; Nadine Hertel; Anja Gabriel; Mark Nuijten; Helen Dakin; Stephen Mitchell; Barbara Poulsen Nautrup
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 9.  Economic evaluation and transferability of physical activity programmes in primary prevention: a systematic review.

Authors:  Silke B Wolfenstetter; Christina M Wenig
Journal:  Int J Environ Res Public Health       Date:  2010-04-09       Impact factor: 3.390

10.  Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany.

Authors:  Stefan Pscherer; Eva Susanne Dietrich; Franz-Werner Dippel; Aileen Rae Neilson
Journal:  Ger Med Sci       Date:  2010-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.